OR WAIT 15 SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
January 04, 2021
Using rDNA technology to synthesize production of proteins and peptide hormones, the biotech startup has achieved synthetic production of insulin, potentially lowering insulin cost by 30%.
August 21, 2020
CDMO Avid Bioservices will provide development and drug substance manufacturing for Oragenics’ novel COVID-19 vaccine candidate, Terra CoV-2.
June 04, 2020
CordenPharma announces expansion of lipid excipients supply for coronavirus vaccine scale up.
June 01, 2020
Therapies for early and late treatment and passive immunization of COVID-19 are needed and can be developed using antibodies from recovered patients.
April 01, 2020
Biopharma companies responding to the COVID-19 outbreak think accelerating the development of vaccines is safe.
February 17, 2020
An evaluation by USP indicates bovine heparin is a potential alternative to porcine heparin.
January 06, 2020
The new GMP conditioning product offering is designed to support clinical phase and commercialization stages of cell and gene therapy production.
September 01, 2019
Innovation in manufacturing technologies must occur to ensure the availability of gene and cell therapies.
February 01, 2019
New platform technologies, advanced modeling tools, and addressing patient needs are important developments.
November 26, 2018
ADC Biotechnology will invest downstream formulation, fill/finish capabilities, and Lock-Release conjugation technology.